Back to expert viewsListen to Dr. C. Michael Gibson and Dr. Serge Korjian discuss expert insights on the recurrent cardiovascular risk in patients with contemporary CV outcomes trials between 2010-2021.
Dr. C. Michael Gibson, Dr. Serge Korijan
Share
Listen to Dr. Susan Gabriel share her insights on risk factors for recurrent cardiovascular events following myocardial infarction in a large real-world data analysis of 78,000 patients with multivessel disease.
Join Dr Kenneth Mahaffey, MD as he explores the impact of recurrent MI and explains why there is currently an unmet need for therapies that can reduce the risk of recurrent cardiovascular events in the high-risk 90-day period after an AMI.
ACC, American College of Cardiology; ACS, acute coronary syndrome; AHA, American Heart Association; AMI, acute myocardial infarction; ApoA-I, apolipoprotein A-I; ASCVD, atherosclerotic cardiovascular disease; CV, cardiovascular; ESC, European Society of Cardiology; HDL, high-density lipoprotein; LDL, low-density lipoprotein
USA-GEN-0051 | August 2023